Skip to main content

Market Overview

Lineage Cell Therapeutics, Inc. (LCTX)

2.71 -0.14 (-4.75%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.05
571K



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.06
514K
-0.04
790K
-0.01
391K
75%
-50.51%
Q4 2020
After-Hours
EPS:
REV:
-0.03
1.241M
-0.05
920K
0.01
355K
120%
-61.41%
Q3 2020
After-Hours
EPS:
REV:
-0.11
567K
-0.04
430K
-0.05
571K
-25%
32.79%
Q2 2020
After-Hours
EPS:
REV:
-0.20
779K
-0.04
560K
-0.04
386K
0%
-31.07%
Q1 2020
After-Hours
EPS:
REV:
0.3
928K
-0.05
710K
-0.06
514K
-20%
-27.61%
Q4 2019
After-Hours
EPS:
REV:
-0.36
758K
-0.05
1.03M
-0.03
1.241M
40%
20.49%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!